Birzeit Pharmaceuticals's earnings have been declining at an average annual rate of -3.1%, while the Pharmaceuticals industry saw earnings growing at 8.1% annually. Revenues have been growing at an average rate of 1.3% per year. Birzeit Pharmaceuticals's return on equity is 10.3%, and it has net margins of 24.9%.
Key information
-3.14%
Earnings growth rate
-3.13%
EPS growth rate
Pharmaceuticals Industry Growth
12.39%
Revenue growth rate
1.34%
Return on equity
10.33%
Net Margin
24.91%
Last Earnings Update
31 Dec 2025
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Birzeit Pharmaceuticals makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
PLSE:BPC Revenue, expenses and earnings (USD Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Dec 25
48
12
7
0
30 Sep 25
47
13
6
0
30 Jun 25
46
13
5
0
31 Mar 25
42
8
5
0
31 Dec 24
41
5
6
0
30 Sep 24
38
4
7
0
30 Jun 24
40
3
7
0
31 Mar 24
42
3
8
0
31 Dec 23
43
6
8
0
30 Sep 23
44
6
7
0
30 Jun 23
45
6
7
0
31 Mar 23
45
7
7
0
31 Dec 22
47
8
7
0
30 Sep 22
47
10
8
0
30 Jun 22
48
12
8
0
31 Mar 22
50
14
7
0
31 Dec 21
45
12
7
0
30 Sep 21
43
11
7
0
30 Jun 21
40
10
7
0
31 Mar 21
35
7
7
0
31 Dec 20
36
7
7
0
30 Sep 20
35
8
7
0
30 Jun 20
35
8
8
0
31 Mar 20
35
8
7
0
31 Dec 19
35
10
7
0
30 Sep 19
33
8
7
0
30 Jun 19
32
7
6
0
31 Mar 19
35
8
6
0
31 Dec 18
36
8
6
0
30 Sep 18
35
10
6
0
30 Jun 18
34
10
6
0
31 Mar 18
33
11
6
0
31 Dec 17
33
11
6
0
30 Sep 17
34
8
6
0
30 Jun 17
34
9
6
0
31 Mar 17
34
8
6
0
31 Dec 16
32
8
5
0
30 Sep 16
30
6
5
0
30 Jun 16
28
5
5
0
31 Mar 16
28
5
5
0
31 Dec 15
26
5
5
0
30 Sep 15
27
5
5
0
30 Jun 15
27
5
5
0
Quality Earnings: BPC has high quality earnings.
Growing Profit Margin: BPC's current net profit margins (24.9%) are higher than last year (12.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BPC's earnings have declined by 3.1% per year over the past 5 years.
Accelerating Growth: BPC's earnings growth over the past year (130.5%) exceeds its 5-year average (-3.1% per year).
Earnings vs Industry: BPC earnings growth over the past year (130.5%) exceeded the Pharmaceuticals industry 7.9%.
Return on Equity
High ROE: BPC's Return on Equity (10.3%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/05/31 20:12
End of Day Share Price
2026/05/10 00:00
Earnings
2025/12/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Birzeit Pharmaceuticals Company is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.